About
Titles
Staff Affiliate - YNHH
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Shannon Sweeney's published research.
Publications Timeline
A big-picture view of Shannon Sweeney's research output by year.
Reza Yaesoubi, PhD
Ted Cohen, DPH, MD, MPH
5Publications
4Citations
Publications
2024
Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysis
Ryckman T, Schumacher S, Lienhardt C, Sweeney S, Dowdy D, Mirzayev F, Kendall E. Economic implications of novel regimens for tuberculosis treatment in three high-burden countries: a modelling analysis. The Lancet Global Health 2024, 12: e995-e1004. PMID: 38762299, PMCID: PMC11126367, DOI: 10.1016/s2214-109x(24)00088-3.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsRifampin-resistant tuberculosisRifampin-susceptible tuberculosisMedium-term costsTuberculosis treatmentRifampin susceptibilityTuberculosis regimensStandard-of-care regimensCost-effective priceEstimated pricePrice thresholdsPriceDrug costsCost-neutralNovel drug combinationsStandard-of-careSouth AfricaTuberculosis treatment regimensEconomic implicationsStandard of carePatient-borne costsHigh-burden countriesCohort of adultsDecision-analytic modelShorter regimensNovel regimensImpact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.
James L, Klaassen F, Sweeney S, Furin J, Franke M, Yaesoubi R, Chesov D, Ciobanu N, Codreanu A, Crudu V, Cohen T, Menzies N. Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis. PLOS Medicine 2024, 21: e1004401. PMID: 38701084, PMCID: PMC11101189, DOI: 10.1371/journal.pmed.1004401.Peer-Reviewed Original ResearchAltmetricConceptsQuality-adjusted life yearsStandard of careDrug susceptibility testingRifampicin-resistant tuberculosisRR-TBEnd-of-treatmentLonger regimensTreatment strategiesTreatment outcomesBurden of drug-resistant TBCost-effective treatment strategyResistance to amikacinDrug-resistant TBSevere adverse eventsHistory of TBResistance to delamanidTB drug resistanceAnti-TB drugsLifetime costsAssociated treatment outcomesFQ-R.Average timeNatural history of TBFluoroquinolone resistanceFQ-RImproving hospital-based opioid substitution therapy (iHOST): protocol for a mixed-methods evaluation
Lewer D, Brown M, Burns A, Eastwood N, Gittens R, Holland A, Hope V, Ko A, Lewthwaite P, Morris A, Noctor A, Preston A, Scott J, Smith E, Sweeney S, Tilouche N, Wickremsinhe M, Harris M. Improving hospital-based opioid substitution therapy (iHOST): protocol for a mixed-methods evaluation. NIHR Open Research 2024, 4: 10. DOI: 10.3310/nihropenres.13534.1.Peer-Reviewed Original ResearchAltmetricConceptsOpioid substitution therapyProcess evaluationMedical adviceAssociated with improved healthQualitative process evaluationHospital-based servicesHealth research projectsMixed-methods evaluationQuasi-experimental quantitative studyDifference-in-differences analysisMixed-methods studyOnline training moduleAdmitted to hospitalControl hospitalsAcute hospitalsImprove careHospital cliniciansEmergency readmissionIllicit opioidsHospital staffQuantitative studyFocus groupsClinical guidelinesSubstitution therapyPrimary outcomeSafe inhalation pipe provision (SIPP): protocol for a mixed-method evaluation of an intervention to improve health outcomes and service engagement among people who use crack cocaine in England
Harris M, Scott J, Hope V, Busza J, Sweeney S, Preston A, Southwell M, Eastwood N, Vuckovic C, McGaff C, Yoon I, Wilkins L, Ram S, Lord C, Bonnet P, Furlong P, Simpson N, Slater H, Platt L. Safe inhalation pipe provision (SIPP): protocol for a mixed-method evaluation of an intervention to improve health outcomes and service engagement among people who use crack cocaine in England. Harm Reduction Journal 2024, 21: 19. PMID: 38263202, PMCID: PMC10804795, DOI: 10.1186/s12954-024-00938-7.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsHealth harmsMixed-methods process evaluationService engagementProcess evaluation interviewsDrug servicesImprove health outcomesMixed-methods evaluationPost-intervention surveysSmoking equipmentHealth risk awarenessParticipant eligibility criteriaImprove service accessReduction service provisionSpecialist drug servicesHarm reduction service provisionAssociated health harmsPrimary outcome measurePipe sharingCrack cocaineProcess evaluationHealth outcomesTraining interventionUnderserved populationsService accessRespiratory harm
2023
A Scoping Review and Taxonomy of Epidemiological-Macroeconomic Models of COVID-19
Bonnet G, Pearson C, Torres-Rueda S, Ruiz F, Lines J, Jit M, Vassall A, Sweeney S. A Scoping Review and Taxonomy of Epidemiological-Macroeconomic Models of COVID-19. Value In Health 2023, 27: 104-116. PMID: 37913921, DOI: 10.1016/j.jval.2023.10.008.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsMacroeconomic projectionsTotal gross domestic productComputable general equilibriumLong-run impactsGross domestic productInput-output modelMacroeconomic impactMacroeconomic outcomesAgent-based modelAggregate consumptionGeneral equilibriumHigh-income countriesDomestic productCountry applicationsMaximization modelMitigation policiesPolicy makersPovertyEpidemiological modelModel methodologyEmpirical dataImpact of lockdownEconomistsCOVID-19 pandemicImpact